The European Commission needs to continue working on the approvals timeline for crops grown with new biotechnology traits, according to the American Soybean Association (ASA).
The ASA wants the commission to give final authorization to new biotech events. European Ombudsman Emily O’Reilly said in January she sees the delays of the previous commission’s decisions as "maladministration."
“While Ombudsman O’Reilly’s report is a reaffirmation of what we have known to be true for some time, it is still a good acknowledgement of the work that is ahead with regard to Europe," ASA President Richard Wilkins said. "The process for approving new traits for export must be a transparent, efficient and science-based one. And the current commission must not shirk its responsibility to provide final authorization of new biotech products after they have traveled through the E.U.’s established reviews and processes."
Several new soybean biotech traits now are awaiting final approval by the commission, which needs to provide final authorizations in accordance with E.U. regulations.